New Biomarker 14-3-3η: Advances in Diagnosing Early Rheumatoid Arthritis and Differentiating Osteoarthritis
Description: Walter Maksymowych, MD, details the differences between rheumatoid arthritis and osteoarthritis, and discusses the limitation of current markers and the benefits of the 14-3-3η biomarker.
At the conclusion of this program, participants will be able to:
• Differentiate Rheumatoid Arthritis (RA) from Osteoarthritis (OA)
• Understand the major limitations of current markers RF and anti-CCP antibody
• Learn how 14-3-3eta can help overcome the seronegativity of RF and anti-CCP antibody in early and established RA
ASCLS P.A.C.E.® credits available to laboratory professionals through April 6, 2015.